Dr. Geschwind has also played a crucial role in more than 50 clinical trials aimed at testing and developing new treatments for liver cancer. These trials have paved the way for cutting-edge therapies, including intraarterial therapy using radioactive microspheres and noninvasive ultrasound-guided treatments for liver and kidney cancer. https://www.bumc.bu.edu/camed/jean-francois-jeff-geschwind-m-d-91-2011-distinguished-alumnus-award/